ResMed | RMD - Trade Creditors

Stock Price
201.88
Daily Change
-0.58 -0.29%
Monthly
-10.16%
Yearly
-19.79%
Q2 Forecast
197.82

ResMed reported $273.3M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Ansell USD 302.3M 51.4M Dec/2025
Artivion USD 18.34M 2.3M Mar/2026
AtriCure USD 70.06M 8.34M Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Cochlear AUD 281.3M 17.1M Dec/2025
Cooper Companies USD 225.8M 74.6M Dec/2025
CSL USD 3.17B 290M Dec/2025
Dexcom USD 1.94B 109.1M Mar/2026
Edwards Lifesciences USD 181.1M 46.4M Mar/2026
Fisher Paykel Healthcare NZD 267.8M 4M Dec/2025
Globus Medical USD 103.66M 4.81M Mar/2026
Haemonetics USD 48.69M 13M Dec/2025
Idexx Laboratories USD 129.97M 19.57M Mar/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 149.8M 74.8M Mar/2026
Integra LifeSciences USD 87.95M 7.78M Mar/2026
Intuitive Surgical USD 1.85B 68.6M Mar/2026
Masimo USD 89M 14M Mar/2026
Medtronic USD 2.57B 12M Dec/2025
Philips EUR 1.99B 63M Mar/2026
Ramsay Health Care AUD 2.02B 289.9M Dec/2025
ResMed USD 273.3M 22.9M Mar/2026
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 338.8M 53.7M Mar/2026
Teleflex USD 143.63M 13.43M Mar/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026